The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis and uterine fibroids , as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. About the Role: The Senior Director, Patient Marketing will lead the strategic vision, investment, and execution of all direct-to-consumer (DTC) marketing efforts across the Ingrezza business, with primary accountability for ~$150M in annual media investment spanning Linear TV, Streaming, Paid Search, Paid Social, Programmatic, Digital Display, and owned patient engagement channels (CRM/email).